On December 22, 2025, representatives from the Greater Health Industry Committee of the Yinzhou Ningbo University Alumni Fellowship visited Zhejiang Tianyuan Biotechnology Co., Ltd. for an exchange tour. Mr. Huang Bisheng, Chairman of the company, and Mr. Jiao Mingming, General Manager, together with their team, warmly received the visiting guests.

      Accompanied by company executives, the delegation toured the Science and Technology Exhibition Hall and laboratories. Through comprehensive displays, the visit fully showcased Tianyuan Biotech’s technical strength in the bio-health sector. The representatives expressed admiration for the company’s innovative achievements in biomedicine and voiced high expectations for its future development potential.

      During the subsequent symposium, both parties engaged in an in-depth discussion on "Establishing Scientific Understanding of Stem Cell Function, Storage, and Application." General Manager Jiao Mingming provided a detailed overview of the company, covering its business layout and scientific research outcomes, offering the representatives a comprehensive understanding of Tianyuan Biotech.

      Dr. Liu Guangcheng, Director of the Cell Laboratory, presented fundamental knowledge about stem cells and highlighted the company’s unique advantages in stem cell technology R&D. Dr. Chen Junjie, Technical Director and Postdoctoral Fellow at Harvard Medical School, showcased the company’s core technological achievements in iPSC (induced Pluripotent Stem Cell) research directions and quality control systems.

      Mr. Dong Jianwei, President of the Yinzhou Ningbo University Alumni Fellowship, Mr. Zhuang Xuedong, Executive President, and other delegation members fully affirmed Tianyuan Biotech’s accomplishments in scientific research and industrial translation. They noted that the company’s exploration and practice in the stem cell field have set a benchmark for industry development, expressing hope for more collaboration opportunities in the future to jointly promote stem cell technologies for the benefit of society.

      This visit and exchange activity by the Greater Health Industry Committee of the Yinzhou Ningbo University Alumni Fellowship has further strengthened ties between alumni and the enterprise, establishing a robust communication platform for cooperation in scientific research, talent cultivation, and industrial synergy. Chairman Huang Bisheng expressed his anticipation for broader collaboration with the alumni association in the greater health industry, aiming to jointly explore the boundless possibilities of biomedical technology and contribute further to the cause of human health.

      Founded in 2017, Zhejiang Tianyuan Biotechnology Co., Ltd. is a national high-tech enterprise dedicated to cell research and development, manufacturing, operations, and services. The company possesses valuable resource banks, including an HLA Umbilical Cord Matching Bank, an iPS Seed Cell Bank, and a Tumor Cell Bank. It is also a participating unit in formulating the group standard for immune function assessment methods under the National Health Commission (NHC). Furthermore, Tianyuan Biotech has co-established the Joint Laboratory for Metabolic Immune Monitoring with the NHC Research Institute, and serves as key research service platforms such as the Ningbo Storage Center of the National Stem Cell Translational Resource Bank and the Achievement Transformation Center of the NHC Research Institute.